Related Experiment Video
Updated: Apr 7, 2026

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
Unique MicroRNA signatures associated with early coronary atherosclerotic plaques
Rong Wang1, Lai-Dong Dong2, Xiang-Bin Meng3
1The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of Health, Shandong University Qilu Hospital, Jinan, Shandong 250012, China.
Abstract:
The pathophysiology of coronary atherosclerotic plaques is a complex process. Early detection of coronary atherosclerotic plaques is critical in the prevention, prognostic and therapeutic intervention of cardiovascular disease. MicroRNAs (miRNAs), endogenous short non-coding RNAs, have been reported to play an important role in cardiovascular diseases and are also used as disease markers. However, the miRNA expression profile in early coronary atherosclerotic plaques has yet been reported. We hypothesize that miRNAs can be used as effective disease markers for detection of early coronary atherosclerotic plaques. In this analysis, coronary artery samples from three patients with early coronary atherosclerosis were harvested and miRNA expression profile determined using microarray analysis. Compared with healthy controls, a total of 44 miRNAs were upregulated and 57 miRNAs were downregulated. Among the dysregulated miRNAs, eight were significantly upregulated while five miRNAs were significantly downregulated, as determined by t-test (P < 0.05). Four of the significantly dysregulated miRNAs, including miR-221, miR-155, miR-100 and hsa-miR-1273, were selected and verified by real-time PCR. The real-time PCR results were consistent with the microarray data that miR-221, miR-155 and miR-100 were significantly downregulated in plaques, whereas miR-1273 was significantly upregulated. These results indicate that miRNAs expression level can be used as potential markers for early coronary atherosclerotic plaque formation.
Insights
MicroRNAs (miRNAs) show altered expression in early coronary atherosclerosis. These small non-coding RNAs could serve as novel biomarkers for detecting early plaque formation in cardiovascular disease.
Area of Science:
- Cardiovascular Biology
- Molecular Diagnostics
- Biomarker Discovery
Background:
- Coronary atherosclerotic plaque pathophysiology is complex, necessitating early detection for effective cardiovascular disease management.
- MicroRNAs (miRNAs) are implicated in cardiovascular diseases and show potential as diagnostic markers.
- The miRNA expression profile in early coronary atherosclerotic plaques remains largely uncharacterized.
Purpose of the Study:
- To investigate the miRNA expression profile in early coronary atherosclerotic plaques.
- To identify potential miRNA biomarkers for the early detection of coronary atherosclerosis.
- To test the hypothesis that miRNAs can serve as effective disease markers for early plaque detection.
Main Methods:
- Microarray analysis of miRNA expression in coronary artery samples from patients with early atherosclerosis.
- Comparison of miRNA expression profiles between atherosclerotic plaques and healthy controls.
- Validation of selected dysregulated miRNAs using real-time PCR.
Main Results:
- A total of 101 miRNAs were found to be differentially expressed (44 upregulated, 57 downregulated).
- Eight miRNAs were significantly upregulated and five were significantly downregulated (P < 0.05).
- Real-time PCR confirmed downregulation of miR-221, miR-155, miR-100 and upregulation of miR-1273 in plaques.
Conclusions:
- Altered miRNA expression levels are associated with early coronary atherosclerotic plaque formation.
- Specific miRNAs, including miR-221, miR-155, miR-100, and miR-1273, show potential as biomarkers for early detection.
- miRNA expression profiling offers a promising avenue for identifying individuals with early-stage coronary atherosclerosis.
More Related Videos
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Coronary Artery Disease II: Pathophysiology
Atherosclerosis I: Introduction

